1-5 of 5
Nadira Durakovic, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Salvage Use of Ibrutinib after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for B Cell Malignancies: A Study of the French Cooperative Group for CLL, the French Soceity for Blood and Marrow Transplantation (SFGM-TC), and the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancy and Lymphoma Working Parties

Mauricette Michallet, MD PhD, Peter Dreger, MD, Mohamad Sobh, PharmD, Jennifer Hoek, Data Manager, Ariane Boumendil, PhD, Lutz Muller, MD, Paolo Corradini, MD, Wolfgang Bethge, MD, Domenico Russo, MD, Nadira Durakovic, MD PhD, Michel van Gelder, MD PhD, Nicolaas PM Schaap, MD, Nicolaus Kroger, MD PhD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4659.
https://doi.org/10.1182/blood.V128.22.4659.4659
Published: 2016
Journal Articles

Ibrutinib for Bridging to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Is Safe and Effective: First Results of a Survey By the Chronic Malignancy and the Lymphoma Working Parties of the EBMT

Peter Dreger, MD, Mauricette Michallet, MD PhD, Jennifer Hoek, Data Manager, Ariane Boumendil, PhD, Mohamad Sobh, PharmD, Lutz Muller, MD, Elisabeth A. Vandenberghe, MB, MRCPI, MRCPath, PhD, Ilaria Scortechini, MD, Niels S. Andersen, MD PhD, Jurgen Finke, MD, Domenico Russo, MD, Jakob R Passweg, MD, Helene Schoemans, MD, Nadira Durakovic, MD PhD, Helene Labussiere, MD, Tobias Berg, MD, Dietger Niederwieser, MD, Wolfgang Bethge, MD, Nicola Mordini, MD, Michel van Gelder, MD PhD, Nicolaas PM Schaap, MD PhD, Nicolaus Kroger, MD PhD, Silvia Montoto, MD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4657.
https://doi.org/10.1182/blood.V128.22.4657.4657
Published: 2016
Journal Articles

Implementation of NIH Criteria for Standardization of Chronic Graft-Versus-Host Disease in Croatia: Two-Year Experience

Lana Desnica, MD, Drazen Pulanic, MD PhD, Ranka Serventi Seiwerth, MD, Nikolina Matic, RN, Marinka Mravak Stipetic, DMD,PhD, Ervina Bilic, MD PhD, Romana Ceovic, MD PhD, Dina Ljubas Kelecic, mr. pharm., Ljubica Rajic, MD PhD, Ernest Bilic, MD PhD, Nadira Durakovic, MD PhD, Zinaida Peric, MD PhD, Tajana Klepac Pulanic, MD, Tamara Vukic, MD, Igor Petricek, MD PhD, Davorka Dusek, MD, Ines Bojanic, MD PhD, Ema Prenc, Mrs., Iva Ozana Prah, PhD, Magdalena Grce, PhD, Renata Zadro, MD PhD, Drago Batinic, MD PhD, Radovan Vrhovac, MD PhD, Steven Z. Pavletic, MD, Damir Nemet, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5580.
https://doi.org/10.1182/blood.V126.23.5580.5580
Published: 2015
Journal Articles

Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide

Wendy Ying, BA, Tracy T. Douglas, RN, MSN, Nadira Durakovic, MD, PhD, Sallie Brovitz-Palmer, RN, MSN, AOCNS, Lindsey Lombardi Thomas, PharmD, Richard J. Jones, Leo Luznik, Ephraim J. Fuchs
Journal: Blood
Blood (2011) 118 (21): 893.
https://doi.org/10.1182/blood.V118.21.893.893
Published: 2011
Journal Articles

Defining An Optimal Therapeutic Range for Busulfan (Bu) Administered with Pre-and Post-Transplant Cyclophosphamide (Cy) In HLA-Matched Related and Unrelated Bone Marrow Transplantation (BMT).

Lindsey R Lombardi, PharmD, Marianna Zahurak, M.S., Nadira Durakovic, MD, PhD, Jeanne Kowalski, PhD, Richard J. Jones, MD, Leo Luznik, MD
Journal: Blood
Blood (2010) 116 (21): 3474.
https://doi.org/10.1182/blood.V116.21.3474.3474
Published: 2010